Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024. This event, held in Tokyo from 27th to 29th October, brings together global leaders in drug development and regulatory science.

The conference will focus on "Driving Patient-Centric Innovation" and offers a unique opportunity for industry professionals to engage in high-level discussions on the latest advancements in drug development, regulatory trends, and innovative technologies in healthcare.

As an attendee, Dr. Taubel will be contributing to the dialogue on cutting-edge clinical research practices. If you would like to connect with us during the event, please feel free to reach out and arrange a meeting.

For more information about the event, please visit the DIA Japan Annual Meeting 2024 website.

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

Women's Health Horizons 2026

22 September 2026
Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026
View event